查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401821

气喘治疗市场，按药物类别、按产品类型、按给药途径、按国家和地区划分 - 2023-2030 年行业分析、市场规模、市场份额和预测

Asthma Therapeutics Market, By Drug Class, By Product Type, By Route of Administrations, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年气喘治疗市场规模为 241 亿美元，2023 年至 2030 年复合CAGR为 5.1%。

气喘治疗市场-市场动态

呼吸系统疾病的激增以及对具有成本效益的治疗方案的需求推动了市场需求

呼吸系统疾病的激增以及对具有成本效益的治疗方案的需求凸显了气喘治疗的重要性。根据世界卫生组织 (WHO) 2023 年 5 月的报告，2019 年约有 2.62 亿人受到气喘影响，导致全球 455,000 人死亡。污染、过敏原、灰尘等室内和室外触发因素的增加以及生活方式的改变等因素预计将推动气喘治疗领域的成长。此外，提高患者、护理人员和医生对气喘的认识和教育可能会增强治疗效果。每年举行的世界气喘大会等活动旨在向专家传播知识和进展，帮助理解这种疾病并推进治疗方案。针对气喘患者的新型药物和设备（例如生物製剂、生物相似药、吸入器、雾化器和智慧型设备）的研发（R＆D）投资预计将加强气喘管理并促进市场扩张。值得注意的是，BiosanaPharma 完成了奥马珠单抗生物相似药的第一期临床试验，奥马珠单抗是 FDA 批准的治疗气喘和慢性特发性荨麻疹的药物。这些突破对于增加患者获得治疗选择至关重要。

气喘治疗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2023-2030 年）每年将以 5.1% 左右的CAGR成长

根据药物类别细分，预计联合疗法将在 2022 年显示最大的市场份额

依产品类型细分，2022年吸入型为主导类型

按地区划分，北美是 2022 年的主要收入来源

气喘治疗市场-細項分析：

全球气喘治疗市场根据药物类别、产品类型、给药途径和地区进行细分。

根据药物类别，市场分为三类：联合疗法、抗发炎药物和支气管扩张剂。 2022 年，联合治疗领域，特别是吸入性皮质类固醇与长效 β 受体激动剂的联合治疗，在治疗类别中占据了主要市场份额。该类药物因其增强的治疗效果、广泛的可用性以及提高患者对药物的依从性而受到讚誉。

市场依给药途径分为三类：口服、吸入和其他方法。 2022年，由于气喘治疗策略中肺部给药系统的采用率较高且患者依从性提高，吸入药物领域占据了最大的收入份额。患者对气喘替代疗法的认识不断提高，以及与这些先进药物传递系统相关的简单性，正在推动该细分市场在预估期间内的成长。

气喘治疗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

气喘治疗市场-竞争格局：

製药和医疗保健领域专门从事气喘治疗的公司采用多种策略来增强其产品。他们的重点仍然是持续研究和开发 (R&D)，以创新和推出新的药物、配方和输送系统。这涉及开发针对特定发炎途径的新药物或引入先进的吸入器技术以更有效地给药。公司优先考虑进行临床试验和实证研究，以展示其气喘药物的有效性和安全性。获得监管部门的批准并遵守严格的标准对于市场渗透和接受至关重要。此外，人们越来越重视个人化医疗方法，旨在根据患者个体特征、遗传学和对治疗的反应来客製化治疗方法。这包括深入研究生物标记和预测分析，以确定可能从特定药物或疗法中获益更多的患者亚群。此外，行销策略的重点是向医疗保健提供者和患者宣传气喘管理的最新进展，强调遵守治疗计划和提高对可用选择的认识的重要性。此外，公司积极参与合作和伙伴关係，与研究机构、倡导团体和医疗保健组织合作，推动创新、加强患者护理并扩大市场占有率。主要行业参与者正在实施各种业务策略来巩固自己的地位，包括新产品发布、获得批准以及进行收购和合併。

最近的发展：

2022 年 2 月，Mankind Pharma 透露与 Dr. Reddy's Laboratories Ltd. 达成协议，收购 Combihale 和 Daffy。用于治疗气喘和慢性阻塞性肺病的吸入器品牌Combihale估值为1.09亿美元，成长率为14%。这项策略性倡议预计将增强该公司的产品组合，并赋予其相对于竞争对手的竞争优势。

目录

第一章：气喘治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按药物类别分類的气喘治疗市场片段
    • 按产品类型分類的气喘治疗市场片段
    • 依给药途径分類的气喘治疗市场片段
    • 按国家/地区分類的气喘治疗市场摘要
    • 按地区分類的气喘治疗市场片段
  • 竞争洞察

第 3 章：气喘治疗主要市场趋势

  • 气喘治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 气喘治疗市场限制
    • 市场限制影响分析
  • 气喘治疗市场机会
  • 气喘治疗市场未来趋势

第 4 章：气喘治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：气喘治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：气喘治疗市场格局

  • 2022 年气喘治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：气喘治疗市场 - 按药物类别

  • 概述
    • 按药物类别分類的细分市场份额分析
    • 消炎剂
    • 支气管扩张剂
    • 联合疗法

第 8 章：气喘治疗市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 吸入器
    • 雾化器

第 9 章：气喘治疗市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 口服
    • 吸入
    • 其他的

第 10 章：气喘治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美哮喘治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按药物类别）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模与预测（按管理途径）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲气喘治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按药物类别）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模与预测（按管理途径）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区气喘治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按药物类别）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（依管理途径）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲哮喘治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按药物类别）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲气喘治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按药物类别）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按管理途径）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 气喘治疗产业

  • 竞争仪表板
  • 公司简介
    • Teva Pharmaceutical Industries Ltd.
    • GSK plc.
    • Merck& Co., Inc.
    • F. Hoffmann-La Roche Ltd
    • AstraZeneca
    • Boehringer Ingelheim International GmbH.
    • Sanofi
    • Koninklijke Philips NV
    • BD
    • Sunovion Pharmaceuticals, Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2007

REPORT HIGHLIGHT

Asthma Therapeutics Market size was valued at USD 24,100 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

Asthma therapeutics encompass a spectrum of medicines and interventions devised to manage and relieve the symptoms of asthma, a persistent respiratory condition marked by airway inflammation and increased responsiveness. These therapies aim to regulate manifestations like wheezing, breath shortness, chest constriction, and coughing. They fall into two primary categories: long-term control drugs that aim to prevent symptoms and diminish airway inflammation, and quick-relief or rescue medications for immediate relief during asthma attacks. Long-term control medications commonly involve inhaled corticosteroids, long-acting beta-agonists, leukotriene modifiers, and biologics, while short-acting beta-agonists and anticholinergics are typically used as rescue drugs. Additionally, treatment plans may incorporate tailored approaches, lifestyle adjustments, and educational programs on managing asthma to enhance individuals' control and enhance their quality of life while reducing the risk of asthma flare-ups. Consistent monitoring and adjustment of treatment by healthcare professionals are crucial for effective asthma care.

Asthma Therapeutics Market- Market Dynamics

Surge in respiratory illnesses alongside the demand for cost-efficient treatment options to propel market demand

The surge in respiratory illnesses alongside the demand for cost-efficient treatment options underlies the significance of asthma therapeutics. According to the World Health Organization's (WHO) May 2023 report, approximately 262 million people were affected by asthma in 2019, resulting in 455,000 global deaths. Factors such as increasing indoor and outdoor triggers like pollution, allergens, dust, and evolving lifestyles are anticipated to drive growth in the asthma therapeutics sector. Furthermore, heightened awareness and education about asthma among patients, caregivers, and medical practitioners are likely to augment treatments. Events like the World Congress of Asthma, held annually to disseminate knowledge and advancements among experts, aid in comprehending the disease and advancing treatment options. Investments in research and development (R&D) for novel drugs and devices catering to asthma patients, such as biologics, biosimilars, inhalers, nebulizers, and smart devices, are expected to enhance asthma management and promote market expansion. Notably, BiosanaPharma completed phase 1 clinical trials for a biosimilar to omalizumab, an FDA-approved drug for asthma and chronic idiopathic urticaria. Such breakthroughs are pivotal in enhancing patient access to treatment options.

Asthma Therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)

Based on Drug Class segmentation, combination therapy was predicted to show maximum market share in the year 2022

Based on Product Type segmentation, inhaled was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Asthma Therapeutics Market- Segmentation Analysis:

The Global Asthma Therapeutics Market is segmented on the basis of Drug Class, Product Type, Route of Administrations, and Region.

The market is divided into three categories based on Drug Class: combination therapy, anti-inflammatory drugs, and bronchodilators. In 2022, the combination therapy segment, notably the combination of inhaled corticosteroids with long-acting beta-agonists, held the primary market share within the therapeutic class. This class is acclaimed for its amplified therapeutic effects, widespread availability, and improved patient adherence to medication.

The market is divided into three categories based on route of administration: oral, inhaled, and other methods. In 2022, the inhaled drugs segment claimed the largest revenue share due to the higher adoption rates and improved patient compliance with pulmonary drug delivery systems in asthma treatment strategies. The escalating awareness among patients regarding alternative asthma therapies and the simplicity associated with these advanced drug delivery systems are driving the growth of this segment over the projected period.

Asthma Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Asthma Therapeutics Market- Competitive Landscape:

Companies specializing in asthma therapeutics in the pharmaceutical and healthcare sectors employ diverse strategies to enhance their offerings. Their focus remains steadfast on continuous research and development (R&D) to innovate and introduce new medications, formulations, and delivery systems. This involves creating novel drugs targeting specific inflammatory pathways or introducing advanced inhaler technologies for more effective drug administration. Companies prioritize conducting clinical trials and evidence-based studies to showcase the efficacy and safety of their asthma medications. Obtaining regulatory approvals and complying with rigorous standards are critical for market penetration and acceptance. Moreover, there is a burgeoning emphasis on personalized medicine approaches, intending to customize treatments based on individual patient characteristics, genetics, and responses to therapies. This includes delving into biomarkers and predictive analytics to identify patient subgroups that may benefit more from specific medications or therapies. Furthermore, marketing strategies center on educating healthcare providers and patients about the latest advancements in asthma management, emphasizing the importance of adhering to treatment plans and increasing awareness about available options. Additionally, companies actively engage in collaborations and partnerships, collaborating with research institutions, advocacy groups, and healthcare organizations to drive innovation, enhance patient care, and broaden their market presence. Key industry players are implementing various business strategies to fortify their positions, including new product launches, obtaining approvals, and engaging in acquisitions and mergers.

Recent Developments:

In February 2022, Mankind Pharma revealed an agreement with Dr. Reddy's Laboratories Ltd. to obtain Combihale and Daffy. Combihale, an inhaler brand used for treating asthma and COPD, was valued at USD 109 million with a growth rate of 14%. This strategic move is anticipated to bolster the company's product portfolio and confer a competitive advantage against its rivals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ASTHMA THERAPEUTICS MARKET KEY PLAYERS

  • Teva Pharmaceutical Industries Ltd.
  • GSK plc.
  • Merck& Co., Inc.
  • F. Hoffmann-La Roche Ltd
  • AstraZeneca
  • Boehringer Ingelheim International GmbH.
  • Sanofi
  • Koninklijke Philips N.V.
  • BD
  • Sunovion Pharmaceuticals, Inc.
  • Others

GLOBAL ASTHMA THERAPEUTICS MARKET, BY DRUG CLASS

  • Anti-inflammatory
  • Bronchodilators
  • Combination Therapy

GLOBAL ASTHMA THERAPEUTICS MARKET, BY PRODUCT TYPE

  • Inhaler
  • Nebulizers

GLOBAL ASTHMA THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATIONS

  • Oral
  • Inhaled
  • Others

GLOBAL ASTHMA THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Asthma Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Asthma Therapeutics Market Snippet by Drug Class
    • 2.1.2. Asthma Therapeutics Market Snippet by Product Type
    • 2.1.3. Asthma Therapeutics Market Snippet by Route of Administration
    • 2.1.4. Asthma Therapeutics Market Snippet by Country
    • 2.1.5. Asthma Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Asthma Therapeutics Key Market Trends

  • 3.1. Asthma Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Asthma Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Asthma Therapeutics Market Opportunities
  • 3.4. Asthma Therapeutics Market Future Trends

4. Asthma Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Asthma Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Asthma Therapeutics Market Landscape

  • 6.1. Asthma Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Asthma Therapeutics Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
    • 7.1.2. Anti-inflammatory
    • 7.1.3. Bronchodilators
    • 7.1.4. Combination Therapy

8. Asthma Therapeutics Market - By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 8.1.2. Inhaler
    • 8.1.3. Nebulizers

9. Asthma Therapeutics Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 9.1.2. Oral
    • 9.1.3. Inhaled
    • 9.1.4. Others

10. Asthma Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Asthma Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Asthma Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Asthma Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Asthma Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Asthma Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Asthma Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Teva Pharmaceutical Industries Ltd.
    • 11.2.2. GSK plc.
    • 11.2.3. Merck& Co., Inc.
    • 11.2.4. F. Hoffmann-La Roche Ltd
    • 11.2.5. AstraZeneca
    • 11.2.6. Boehringer Ingelheim International GmbH.
    • 11.2.7. Sanofi
    • 11.2.8. Koninklijke Philips N.V.
    • 11.2.9. BD
    • 11.2.10. Sunovion Pharmaceuticals, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Asthma Therapeutics Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Asthma Therapeutics Market, by Drug Class 2018-2030 (USD Million)
  • TABLE Asthma Therapeutics Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Asthma Therapeutics Market, by Product Type 2018-2030 (USD Million)
  • TABLE Asthma Therapeutics Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Asthma Therapeutics Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Asthma Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Asthma Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)